ILIAD 02/06/2021 AGM
O.1Approve Financial Statements and Statutory Reports Oppose
O.2Approve Consolidated Financial Statements and Statutory Reports Oppose
O.3Approve Allocation of Income and Dividends of EUR 3 per Share For
O.4Approve Related Party TransactionFor
O.5Renew Appointment of Deloitte & Associes as Auditor Oppose
O.6Renew Appointment of BEAS as Alternate Auditor For
O.7Elect Xavier Niel - Chair (Executive)Oppose
O.8Elect Bertille Burel - Non-Executive DirectorFor
O.9Elect Virginie Calmels - Non-Executive DirectorOppose
O.10Elect Esther Gaide - Non-Executive DirectorFor
O.11Approve Remuneration of Directors in the Aggregate Amount of EUR 350,000 Oppose
O.12Approve the Remuneration ReportFor
O.13Approve Compensation of Xavier Niel, Vice-CEO Until March 16, 2020 For
O.14Approve Compensation of Xavier Niel, Chairman of the Board Since March 16, 2020 For
O.15Approve Compensation of Maxime Lombardini, Chairman of the Board Until March 16, 2020 For
O.16Approve Compensation of Thomas Reynaud, CEO Oppose
E.17Approve the Remuneration ReportOppose
E.18Approve Compensation of Antoine Levavasseur, Vice-CEO Oppose
O.19Approve Remuneration Policy of Chairman of the Board For
O.20Approve Remuneration Policy of CEO Oppose
O.21Approve Remuneration Policy of Vice-CEOs Oppose
O.22Approve Remuneration Policy of Directors For
O.23Authorize Repurchase of Up to 10 Percent of Issued Share Capital Oppose
E.24Authorize Issuance of Equity or Equity-Linked Securities with Preemptive Rights up to Aggregate Nominal Amount of EUR 5 Million For
E.25Authorize Issuance of Equity or Equity-Linked Securities without Preemptive Rights Up to 20 Percent of Issued Capital Oppose
E.26Approve Issuance of Equity or Equity-Linked Securities for up to 20 Percent of Issued Capital Per Year for Private Placements Oppose
E.27Authorize Board to Set Issue Price for 10 Percent Per Year of Issued Capital Pursuant to Issue Authority without Preemptive Rights For
E.28Authorize Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Above Oppose
E.29Authorize Capital Increase of up to 10 Percent of Issued Capital for Contributions in Kind For
E.30Authorize Capital Increase of Up to EUR 2 Million for Future Exchange Offers For
E.31Authorize Capitalization of Reserves of Up to EUR 500 Million for Bonus Issue or Increase in Par Value For
E.32Authorize Capital Issuances for Use in Employee Stock Purchase Plans Oppose
E.33Authorise Cancellation of Treasury SharesFor
E.34Amend Quorum Requirements and Amend Bylaws Accordingly For
E.35Authorize Filing of Required Documents/Other Formalities For